Medical/Pharmaceuticals

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along wit...

2025-02-06 19:40 4847

Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer

SUZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (...

2025-02-06 14:05 4407

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy, Medidata is transforming how industries are empowering patients with new cure and care experiences and lifelong engagement SINGAPORE, Feb. 6, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes brand, reaffirms its vision and c...

2025-02-06 13:00 5498

St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services

PALM BEACH GARDENS, Fla., Feb. 6, 2025 /PRNewswire/ -- St. Luke's Medical Center  has achieved another significant milestone, becoming the first and only hospital inthe Philippines to receive accreditation from the esteemed Global Healthcare Accreditation (GHA). This outstanding accomplishment und...

2025-02-06 09:00 2779

GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC

GCCL is committed to customer success, emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research analyses. SAN ANTONIO, Feb. 6, 2025 /PRNewswire/ -- Frost & Sullivan recently assessed the clinical ...

2025-02-06 02:30 3191

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

* Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC * Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC * Serplulimab has now been approved in China, Europe, and sev...

2025-02-05 22:05 5013

AI & Genomics Advances Bring New Hope to Lung Cancer Burden in Asia

SINGAPORE, Feb. 5, 2025 /PRNewswire/ -- Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1). Many countries have applied low-dose CT scans to screen for this deadly cancer to improve early detection an...

2025-02-05 14:00 7268

Aussie sleeptech firm unveils breakthrough test

MELBOURNE, Australia, Feb. 5, 2025 /PRNewswire/ -- Australian medical technology company Optalert has revealed a breakthrough test for sleep issues, expanding access to sleep health technologies for millions of Australians. The simple test is conducted within 10 minutes on a smartphone, making it...

2025-02-05 13:36 3177

Biomedical engineer's innovative excellence acknowledged

ADELAIDE, Australia, Feb. 5, 2025 /PRNewswire/ -- University of Adelaide Associate ProfessorJiawen Li has been awarded a prestigious global award by tech giant Sony and scientific publishing company Nature, for her work in biomedical engineering.   Meet Dr Jiawen Li, the fir...

2025-02-05 10:19 3174

EyeYon Medical Expands into China with New Subsidiary

ZHUHAI, China, Feb. 5, 2025 /PRNewswire/ -- EyeYon Medical is proud to announce its expansion inChina with the establishment of a new subsidiary, Zhuhai EyeYon Medical Technology Co., Ltd. (珠海爱眼医疗科技有限公司), which will address unmet market needs as well as accelerate its growth trajectory. This stra...

2025-02-05 09:00 3769

Patient Advocates from NCCN Guidelines Panels Share Their 'United by Unique' Stories for World Cancer Day

The National Comprehensive Cancer Network joins a global day of advocacy to put people's individual needs and stories at the forefront of cancer care. PLYMOUTH MEETING, Pa., Feb. 4, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is joining people and organizations across...

2025-02-04 21:11 2788

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book,Pulse...

2025-02-04 16:00 3212

LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

JOHNSON CITY, Tenn., Feb. 4, 2025 /PRNewswire/ -- LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its inaugural members. This board will further cement LabC...

2025-02-04 02:02 3754

United Imaging Unveils Groundbreaking Innovations and Strengthens Strategic Partnerships across the Middle East and Africa at Arab Health 2025

DUBAI, UAE, Feb. 1, 2025 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has showcased a series of game-changing innovations at Arab Health 2025, solidifying pivotal partnerships with healthcare and technology leaders. With an...

2025-02-01 13:00 6452

DRG Is Launching Innovative Traumatic Brain Injury (TBI) Test Panel at MEDLAB in Dubai

MARBURG, Germany, Jan. 31, 2025 /PRNewswire/ -- DRG Instruments GmbH ("DRG") has been a top developer and manufacturer of immunoassays for over 50 years. The company is creating a new division, DRG Neuroscience, and the new division is presenting on the market its fully automated CLIA tests for e...

2025-01-31 21:00 4381

VISTA Eye Specialist Honored as One of Asia's Top Private Hospitals by Newsweek for 2025

PETALING JAYA, Malaysia, Jan. 31, 2025 /PRNewswire/ -- VISTA Eye Specialist (VISTA) is proud to announce its inclusion amongAsia's Top Private Hospitals for 2025, as recognized by the prestigious Newsweek magazine.This accolade highlights VISTA's unwavering dedication to providing exceptional eye...

2025-01-31 08:00 5763

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition includes a pipeline of next...

2025-01-31 06:01 5385

Advanced Sterilization Technology and Picarro Partner to Streamline Process Optimization and EtO Emissions Compliance for Sterilization Facilities

New AST BOAZ EtO Reclamation System integrates with Picarro EtO Monitoring Systems to reduce EtO usage and costs while ensuring regulatory compliance SANTA CLARA, Calif., Jan. 30, 2025 /PRNewswire/ -- Picarro Inc., a global leader in gas monitoring, analytics, and services, has been selected by ...

2025-01-30 23:10 4866

Zeus To Launch Next-Gen Film-Cast PTFE Liners Engineered for Flexibility and Superior Strength

Unveiling at MD&M West, the new StreamLiner™ NG catheter liners minimize defects and maximize performance vs. existing film-cast PTFE liners. ORANGEBURG, S.C., Jan. 30, 2025 /PRNewswire/ -- Zeus, a global leader in advanced polymer solutions and catheter manufacturing, announced today its plans ...

2025-01-30 22:00 4677

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical isotope will enable Isotopia's production of Terbium-161 (Tb-161), a medical isoto...

2025-01-30 12:00 4339
1 ... 120121122123124125126 ... 381